4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-062977
General Counsel sold 420 shares at $0.75 ($315)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-17 | Sale : show line 1 in the form | −420 | $0.75 | $315 | 220,496 | D |
| Open-market sales · 420 sh · avg $0.75 · $315 | ||||||
Loading xslF345X05/ownership.xml…